Ignite Creation Date:
2025-12-24 @ 7:47 PM
Ignite Modification Date:
2025-12-29 @ 1:23 AM
Study NCT ID:
NCT06668103
Status:
RECRUITING
Last Update Posted:
2024-12-12
First Post:
2024-10-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Firmonertinib
Sponsor:
Abbisko Therapeutics Co, Ltd
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ABSK043-202
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None